ArticleNational journal of maxillofacial surgery
Clinical & biochemical evaluation of herbal extract on submucous fibrosis.
Article in National journal of maxillofacial surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral submucous fibrosis (OSMF) is a prevalent disease in India, mainly caused by tobacco chewing (areca nut, pan masala, and betel quid). Its treatment is still under debate, as none of the treatment modalities have been statistically superior to one another, may it be medical or surgical. Aim and Objective: Clinical and interleukin-6 (IL-6) assessment in patients of submucous fibrosis at baseline and 3 months of follow-up, after intervening their usual treatment with the herbal extract. Methodology: Sixty patients were randomly divided into two groups. Group 1 was given the standard treatment, while group 2 was given herbal extract along with the standard treatment. Results: A significant reduction ( Discussion: Sphaeranthus, Ocimum, and honey are already being used, separately or together, in many diseases as anti-inflammatory, antimicrobial, and antioxidant. Conclusion: The herbal extract, used in this study, can be used as an adjunct in OSMF for alleviating the painful symptoms at an early stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.